The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Arcus Biosciences Inc COM 03969F109 61,809 5,049,786 SH   DFND   0 5,049,786 0
Arris Intl Inc SHS G0551A103 237,202 9,703,500 SH   DFND 1 0 9,703,500 0
Arsanis Inc COM 042873109 9,831 451,362 SH   DFND   0 451,362 0
Autolus Therapeutics PLC SPON ADS 05280R100 19,130 714,072 SH   DFND   0 714,072 0
Cloudera Inc COM 18914U100 11,668 855,420 SH   DFND   0 855,420 0
Denali Therapeutics Inc COM 24823R105 8,180 536,411 SH   DFND   0 536,411 0
DocuSign Inc COM 256163106 77,366 1,461,106 SH   DFND   0 1,461,106 0
Dropbox Inc CL A 26210C104 423 13,033 SH   DFND   0 13,033 0
Evelo Biosciences Inc COM 299734103 12,514 1,060,495 SH   DFND   0 1,060,495 0
Forty Seven Inc COM 34983P104 24,735 1,545,966 SH   DFND   0 1,545,966 0
JD com Inc SPON ADR CL A 47215P106 527,908 13,553,474 SH   DFND 1 0 13,553,474 0
Magenta Therapeutics Inc COM 55910K108 45,078 3,339,138 SH   DFND   0 3,339,138 0
Pluralsight Inc CL A 72941B106 2,480 101,442 SH   DFND   0 101,442 0
Snap Inc CL A 83304A106 34,277 2,618,548 SH   DFND   0 2,618,548 0
Spero Therapeutics Inc COM 84833T103 16,320 1,112,473 SH   DFND   0 1,112,473 0
Square Inc CL A 852234103 1,812 29,400 SH   DFND 1 0 29,400 0
Zscaler Inc COM 98980G102 99,691 2,788,560 SH   DFND   0 2,788,560 0